Description

After this webinar attendees will be able to answer: 

• When may a provider consider waiving a patient's copayment, deductible, or coinsurance—and when could a routine waiver create compliance concerns? 
• What is the difference between a legitimate individualized financial-hardship decision and a routine patient-balance waiver? 
• How can the Federal Anti-Kickback Statute and Beneficiary Inducements Civil Monetary Penalty rules affect cost-sharing decisions involving Federal health care program beneficiaries? 
• How should organizations distinguish Medicare and other Federal-program requirements from commercial payer and self-pay situations? 
• Can a provider offer prompt-pay or self-pay discounts, and what should be reviewed before approving them? 
• What documentation should support financial hardship, charity care, payment plans, discounts, write-offs, and other exceptions? 
• Could inconsistent copay collection create payer-contract, state-law, compliance, or revenue concerns? 
• What should compliance officers and auditors look for when reviewing accounts receivable, collection patterns, patient credit balances, and waived balances? 
• Are front-office and billing teams following one written policy—or making case-by-case decisions without sufficient documentation or approval? 
• How can organizations strengthen patient collections without creating unnecessary compliance exposure or preventable revenue leakage? 

Webinar details: 

Patient cost-sharing decisions often appear operational: collect the copay, offer a payment plan, approve financial assistance, write off a balance, or make an exception. 

For compliance officers, auditors, CFOs, CEOs, and revenue-cycle leaders, however, the more important question is: 

Can the organization explain and document why the patient's financial responsibility was reduced or waived? 

The webinar examines the federal and state compliance considerations surrounding copayments, deductibles, coinsurance, routine waivers, financial hardship, prompt-payment discounts, self-pay policies, patient collections, payment plans, bad debt, and account write-offs. It also addresses differences between Federal health care programs and commercial payer arrangements.

Routine or poorly controlled waivers can create several types of exposure. For Federal health care program beneficiaries, cost-sharing waivers may implicate the Federal Anti-Kickback Statute and Beneficiary Inducements Civil Monetary Penalty provisions depending on how the arrangement is structured and why the waiver is being offered. 

Commercial payer arrangements present a different set of considerations. Provider contracts, state requirements, usual-and-customary charge issues, discount policies, and collection practices can all influence whether a discount or waiver is appropriate. 

This session helps healthcare organizations examine the practical questions behind patient financial responsibility: 

What should be collected? When may an exception be appropriate? Who should approve it? What should be documented? And how can the organization demonstrate that exceptions are not simply routine business practice? 

Particular attention is given to: 

• Routine versus individualized waivers 
• Financial-hardship policies 
• Charity-care policies 
• Prompt-payment discounts 
• Self-pay policies 
• Medicare and Federal health care program considerations 
• Commercial payer requirements 
• Patient Financial Responsibility Forms 
• Payment-at-time-of-service practices 
• Payment plans 
• Accounts receivable 
• Patient credit balances 
• Bad debt and write-off policies 
• Documentation and approval controls 
• Collection policies and procedures 
• Training for billing and front-office staff 

For compliance officers and internal auditors, this provides a framework for identifying patterns that may require closer review. 

For CFOs and revenue-cycle leaders, it also addresses the financial side of weak collection practices: unnecessary write-offs, inconsistent collection behavior, and legitimate revenue that may never be recovered. 

Important Current Update – 2026 OIG Clarification 

HHS-OIG has provided important current clarification on patient cost-sharing waivers and financial assistance. 

OIG explains that, as a general matter, the Federal Anti-Kickback Statute and Beneficiary Inducements CMP do not apply to cost-sharing waivers provided to uninsured individuals or individuals insured solely by commercial health plans, including qualified health plans. Other laws, contractual requirements, or state rules may still need to be evaluated.

The analysis changes when Federal health care program beneficiaries are involved. 

OIG continues to express concern about hospitals that routinely waive patient cost-sharing without an individualized, good-faith assessment of financial hardship. Depending on the facts, those arrangements can implicate the Anti-Kickback Statute, the Beneficiary Inducements CMP, or both. cite turn view.

At the same time, OIG makes an important distinction: appropriate financial assistance is not automatically prohibited. 

OIG indicates that financial-need-based waivers may present lower risk when, among other applicable requirements, they are: 

• Not routine 
• Not improperly advertised or used to solicit patients 
• Based on an individualized determination of financial need 
• Supported by an appropriately structured financial-assistance policy 

OIG also recognizes specific regulatory protections for certain arrangements, including an available safe harbor involving qualifying waivers of inpatient hospital cost sharing.

What this means for compliance leaders 

The current message is more nuanced than simply: 

“Never waive a copay.” 

A better compliance question is: 

“Can we demonstrate that the waiver was permitted, individually evaluated where required, consistently approved, and properly documented?” 

That makes written policies, approval authority, hardship criteria, collection records, and audit trails particularly important. 

Marketing accuracy note: 
This OIG clarification is a current regulatory development added to strengthen the marketing context. It should not be represented as material specifically taught in the original recording unless the presentation has been updated to address it. 

This webinar benefits the following agencies / organizations: 

• Hospitals and health systems 
• Physician practices 
• Medical groups 
• Ambulatory and outpatient organizations 
• Specialty practices 
• Healthcare clinics 
• Revenue-cycle organizations 
• Medical billing companies 
• Patient financial services departments 
• Organizations participating in Medicare or other Federal health care programs 
• Healthcare compliance and audit departments 

Primary Regulatory Relevance 

• U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG) 
• Centers for Medicare & Medicaid Services (CMS) 
• Federal Anti-Kickback Statute 
• Beneficiary Inducements Civil Monetary Penalty provisions 
• Medicare patient cost-sharing requirements 
• Applicable state laws 
• Commercial payer contractual requirements 

Who should attend? 

• Chief Compliance Officers 
• Compliance Officers 
• Directors of Compliance 
• Chief Executive Officers 
• Chief Financial Officers 
• Chief Operating Officers 
• Internal Auditors 
• Medical Auditors 
• Revenue Cycle Directors 
• Revenue Cycle Managers 
• Patient Financial Services Directors 
• Billing Directors 
• Billing Managers 
• Medical Billers 
• Practice Administrators 
• Practice Managers 
• Clinic Owners 
• Healthcare CPAs 
• Risk Officers 
• Regulatory Affairs Professionals 
• General Counsel 
• Healthcare Attorneys 
• Compliance Attorneys 
• Patient Access Leaders 
• Accounts Receivable Managers 
• Financial Assistance / Charity Care Teams 
• Professionals responsible for patient collections, discounts, waivers, or financial policies